Atorvastatin treatment modulates the interaction between leptin and adiponectin, and the clinical parameters in patients with type II diabetes

about

The Effect of Renal Denervation on Plasma Adipokine Profile in Patients with Treatment Resistant Hypertension.Association of adiponectin protein and ADIPOQ gene variants with lumbar disc degeneration.Statins decrease leptin expression in human white adipocytes.

P2860

Q33736684-F2C0C613-60E3-4DB6-9D71-B4BBF289028E Q34119529-45D6C136-4609-4F41-8CAD-D0D570B8C8EC Q49413115-B26D3A63-7690-49BA-8A68-FFD3C4DAA980

P2860

Atorvastatin treatment modulates the interaction between leptin and adiponectin, and the clinical parameters in patients with type II diabetes

Item

http://www.wikidata.org/entity/Q41949358

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Atorvastatin treatment modulat ...... patients with type II diabetes

@en

type

Item

label

Atorvastatin treatment modulat ...... patients with type II diabetes

@en

prefLabel

Atorvastatin treatment modulat ...... patients with type II diabetes

@en

P1476

Atorvastatin treatment modulat ...... patients with type II diabetes

@en

P2093

Mera A Ababneh

http://www.w3.org/2001/XMLSchema#string

Omar F Khabour

http://www.w3.org/2001/XMLSchema#string

Raya N Alzayadeen

http://www.w3.org/2001/XMLSchema#string

Sayer I Al-Azzam

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

Lipids, lipid-lowering therapy and diabetes complications.

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

The relationship of adiponectin/leptin ratio with homeostasis model assessment insulin resistance index and metabolic syndrome in apparently healthy korean male adults

The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome

Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients.

Implications of plasma concentrations of adiponectin in patients with coronary artery disease.

P304

1565-1569

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2013.1347

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karem H. Alzoubi

Asem Alkhateeb

P577

2013-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258768625

http://www.w3.org/2001/XMLSchema#string

P698

24255692

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3829757

http://www.w3.org/2001/XMLSchema#string

Atorvastatin treatment modulates the interaction between leptin and adiponectin, and the clinical parameters in patients with type II diabetes

about

P2860

P2860

Atorvastatin treatment modulates the interaction between leptin and adiponectin, and the clinical parameters in patients with type II diabetes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932